| 注册
首页|期刊导航|国际妇产科学杂志|子痫前期的中药临床应用与现代药理学进展

子痫前期的中药临床应用与现代药理学进展

任毅 胡玉莲 王新 张琦 刘超 高慧婕

国际妇产科学杂志2024,Vol.51Issue(4):442-447,6.
国际妇产科学杂志2024,Vol.51Issue(4):442-447,6.DOI:10.12280/gjfckx.20240382

子痫前期的中药临床应用与现代药理学进展

Clinical Application and Modern Pharmacological Progress of Traditional Chinese Medicine in Preeclampsia

任毅 1胡玉莲 2王新 3张琦 4刘超 3高慧婕3

作者信息

  • 1. 264000 山东省烟台市,滨州医学院药学院
  • 2. 日照市人民医院妇产科
  • 3. 济宁医学院药学院
  • 4. 山东省第一医科大学药学院
  • 折叠

摘要

Abstract

Preeclampsia is a pregnancy-related disease clinically characterized by high blood pressure and proteinuria after 20 weeks of gestation.Preeclampsia is a serious danger to the life and health of mothers and infants,and is one of the main causes of maternal and perinatal mortality.For the past few years,multiple Chinese herbal formulas and Chinese medicine injections have been shown to prevent and treat preeclampsia,and good clinical efficacy has been achieved.Modern pharmacological studies have found that Puerarin,Gastrodin,Rhynchophylline,Ginsenoside,Atractylenolide,Danshensu,Tetramethylpyrazine,Astragaloside can promote trophoblast proliferation and invasion,improve the process of pregnancy in experimental animals and play a positive role in the treatment of preeclampsia.Through the relevant literature and analysed the rationality of the clinical use of traditional Chinese medicines by combining clinical efficacy and mechanism studies,this research aims to accelerate and promote the clinical application and development of traditional Chinese medicine in the prevention and treatment of preeclampsia.

关键词

先兆子痫/滋养细胞/治疗结果/中药/药理学

Key words

Pre-eclampsia/Trophoblastic cell/Treatment outcome/Traditional Chinese drugs/Pharmacology

引用本文复制引用

任毅,胡玉莲,王新,张琦,刘超,高慧婕..子痫前期的中药临床应用与现代药理学进展[J].国际妇产科学杂志,2024,51(4):442-447,6.

基金项目

山东省自然科学基金(ZR2021MH164) (ZR2021MH164)

济宁医学院贺林院士新医学临床转化工作站科研基金(JYHL2021MS08) (JYHL2021MS08)

国际妇产科学杂志

OACSTPCD

1674-1870

访问量0
|
下载量0
段落导航相关论文